Johns Hopkins Diabetes GuideMedicationsObesity

Lorcaserin

Clare Lee, M.D., Brian Pinto, Pharm.D
Lorcaserin is a topic covered in the Johns Hopkins Diabetes Guide.

To view the entire topic, please or purchase a subscription.

Johns Hopkins Guides provide diagnosis, management, and treatment guidance for infectious diseases, diabetes, and psychiatric conditions. Explore these free sample topics:

Johns Hopkins Guides

~~ The first section of this topic is shown below ~~

INDICATIONS

FDA

  • Indicated for obese patients with an initial body mass index (BMI) ≥ 30 kg/m2, or overweight patients with a BMI ≥ 27 kg/m2 in the presence of at least one weight related comorbid condition (e.g., hypertension, dyslipidemia, cardiovascular disease, glucose intolerance, sleep apnea) for weight loss and maintenance of weight loss
  • Should be used in conjunction with a reduced-calorie diet and a program of regular exercise
  • Approved for adults, age 18 and older

~~ To view the remaining sections of this topic, please
or purchase a subscription ~~

Last updated: September 26, 2013